What is Panacea Life Sciences Holdings Financial Strength?
Panacea Life Sciences Holdings has the Financial Strength Rank of 0.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:
1. The debt burden that the company has as measured by its
Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3.
Altman Z-Score.
Panacea Life Sciences Holdings did not have earnings to cover the interest expense.
Panacea Life Sciences Holdings's debt to revenue ratio for the quarter that ended in Sep. 2024 was 5.89.
As of today, Panacea Life Sciences Holdings's Altman Z-Score is -5.14.
Competitive Comparison of Panacea Life Sciences Holdings's Financial Strength
For the Drug Manufacturers - Specialty & Generic subindustry, Panacea Life Sciences Holdings's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Panacea Life Sciences Holdings's Financial Strength Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Panacea Life Sciences Holdings's Financial Strength distribution charts can be found below:
* The bar in red indicates where Panacea Life Sciences Holdings's Financial Strength falls into.
Panacea Life Sciences Holdings Financial Strength Calculation
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Panacea Life Sciences Holdings's Interest Expense for the
months ended in Sep. 2024 was $-0.48 Mil. Its Operating Income for the
months ended in Sep. 2024 was $-0.67 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $6.51 Mil.
Panacea Life Sciences Holdings's Interest Coverage for the quarter that ended in Sep. 2024 is
| Panacea Life Sciences Holdings did not have earnings to cover the interest expense. |
The higher the ratio, the stronger the company's financial strength is.
2. Debt to revenue ratio. The lower, the better.
Panacea Life Sciences Holdings's Debt to Revenue Ratio for the quarter that ended in Sep. 2024 is
3. Altman Z-Score.
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
Panacea Life Sciences Holdings has a Z-score of -5.14, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.
Warning Sign:
Altman Z-score of -5.14 is in distress zone. This implies bankruptcy possibility in the next two years.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Panacea Life Sciences Holdings Business Description
Traded in Other Exchanges
N/A
Address
5910 S University Boulevard, C18-193, Greenwood Village, CO, USA, 80121
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. Its products are CBD Softgels, CBD Tablets, CBD Topicals, CBD Skin Care, CBD Tinctures, CBD Edibles, CBD Patches, CBD Pets, and PPE.
Executives
| Leslie Buttorff |
director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER |
16194 W 45TH DRIVE, GOLDEN CO 80403 |
| Janice Nerger |
director |
5910 S UNIVERSITY BLVD., C18-193, GREENWOOD VILLAGE CO 80121 |
| Nathan Joel Berman |
officer: CONTROLLER & PRIN ACTNG OFCR |
16194 W 45TH DRIVE, GOLDEN CO 80403 |
| 22nd Century Group, Inc. |
10 percent owner |
8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221 |
| Harvey J Kesner |
10 percent owner |
65 E. 55TH STREET, NEW YORK NY 10022 |
| Lawrence Wert |
director |
170 NUTTALL RD, RIVERSIDE IL 60546 |
| Chesne Derek Du |
officer: Chief Growth Officer |
80 NE 4TH AVENUE, SUITE 28, DELRAY BEACH FL 33483 |
| Alvaro Daniel Alberttis |
director |
80 NE 4TH AVENUE, SUITE 28, DELRAY BEACH FL 33483 |
| Vladislav Yampolsky |
director, 10 percent owner |
332 PLAZA REAL, BOCA RATON FL 33432 |
| Steven A Schwartz |
director |
332 PLAZA REAL, BOCA RATON FL 33432 |
| Andrew L. Johnson |
officer: Chief Strategy Officer |
80 NE 4TH AVE. SUITE 28, DELRAY BEACH FL 33483 |
| Emiliano Angel Aloi |
officer: President |
510 SUNSHINE DRIVE, DELRAY BEACH FL 33444 |
| Jonathan Gilbert |
director, officer: Executive Chairman |
36 SYCAMORE LANE, ROSALYN HEIGHTS NY 11577 |
| John C Price |
director |
4721 IRONTON STREET, BUILDING A, DENVER CO 80239 |
| Kevin James Esval |
director |
NEURO HITECH INC, ONE PENN PLAZA STE 1503, NEW YORK NY 10019 |
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PLSH has been successfully added to your